Enki Life Science Limited, a active public limited company, was established on 22 June 2000 in Thane, Maharashtra, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U74110MH2000PLC127327. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹1.72 Cr.
Formerly known as Sharon Biotech Limited. It upholds a compliant status. Its leadership includes Vineeta Bulusu (Director), Preeti Shambhuprasad Misra (Additional Director), Prashant Ghildiyal (Director). Past directors included Vijay Rajagopalan, Chrisma Jovana Pereira, Vineeta Bulusu. It holds ₹1.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No 310/312, Plot No 39/5,39/5A Bsel Tech Park,, Sector 30A, Opp Vashi Railway Station, Vashi, Thane, Maharashtra, 400703.
U74110MH2000PLC127327
127327
22 June 2000
₹5.00 Cr
₹1.72 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Enki Life Science Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vineeta Bulusu | Director | 13 Jan 2015 | Current |
| Preeti Shambhuprasad Misra | Additional Director | 17 Apr 2025 | Current |
| Prashant Ghildiyal | Director | 30 Sep 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 15 Feb 2012 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2015 | Past |
| Pramod Abcsdd | Director | 13 Jan 2015 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 10 Jan 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enki Life Science Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 27.02% decrease. The company also saw a substantial fall in profitability, with a 120% decrease in profit. The company's net worth dipped by a decrease of 1.7%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Enki Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹15,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jan 2006 | Uti Bank Ltd. | ₹1.50 Cr | Open |
Explore comprehensive loan charge details -
Enki Life Science has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Enki Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enki Life Science's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Preeti Shambhuprasad Misra was appointed as a Additional Director was appointed as a Additional Director on 17 Apr 2025 & has been associated with this company since 7 months 13 days . was recorded as a recent event.
Progress on Enki Life Science Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Enki Life Science Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on Prashant Ghildiyal was appointed as a Director was appointed as a Director on 30 Sep 2017 & has been associated with this company since 8 years 2 months . was documented.
Vineeta Bulusu was appointed as a Director was appointed as a Director on 13 Jan 2015 & has been associated with this company since 10 years 10 months . was recorded as a recent event.
A charge with Uti Bank Ltd. amounted to Rs. 1.50 Cr with Charge ID 90371909 was registered on 23 Jan 2006. was recorded as a recent event.
The CIN of Enki Life Science Limited is U74110MH2000PLC127327.
Enki Life Science Limited is headquartered at Office No 310/312, Plot No 39/5,39/5A Bsel Tech Park,, Sector 30A, Opp Vashi Railway Station, Vashi, Thane, Maharashtra, 400703.
Enki Life Science Limited was incorporated on 22 June 2000.
The current directors of Enki Life Science Limited are
The primary industry of Enki Life Science Limited is Manufacturing.
Enki Life Science Limited is unlisted.
The authorized capital of Enki Life Science Limited is ₹5.00 Cr, and the paid-up capital is ₹1.72 Cr.
The compliance status of Enki Life Science Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX